Tag: Telomir Pharmaceuticals

Telomir Pharmaceuticals Sees 39% Surge After Positive Study Results

Telomir shares soared 38% after Telomir-1 showed potential to reverse DNA methylation in prostate cancer, restoring key tumor-suppressing genes.